 |
| Today's Blog Posts: |
 |
 PHOSITA:
Phosita ::: quick links for 2008-04-07...
Love, Pending: "Ellie, if you will marry me..." An interesting published patent application - including a means for making a marriage proposal. (tags: ... |
| April 7, 2008 |
|
|
Promote the Progress:
Special price on new FirstPage Weekly service for Promot...
Since launching our innovative FirstPage Reports(tm) on PatentFizz a couple weeks ago, we've received some wonderful feedback from our customers. Many have told us that the Reports are scratching an itch they've had for awhile - the need for an easy to generate overview document for their patent projects. ... |
| November 27, 2007 |
|
|
|
|
| Online Resource Center: |
|
| Primers, Forms, Resource Documents, etc. |
|
|
|
|
|
|
Life Sciences and Pharmaceuticals Practice Group
 Biotechnology is the buzzword of the 21st Century, and DCR's Life Sciences and Pharmaceuticals
Group provides the insight and practical advice required by innovative companies to compete
effectively in the marketplace. Over the past 20 years, life sciences, biotechnology, and
pharmaceutical ventures set new records for research and capital investment. Just as the life
sciences are the building blocks of life itself, new biotechnologies consistently push the intellectual
property envelope, requiring highly specialized and focused representation. DCR assists many of
these emerging growth companies in the development of their business plans, as well as securing
strategic life science patent portfolios that are used for offense as well as defense.
Our life sciences and pharmaceutical practice has grown with the evolving needs of our clients.
This evolution is evident in the increased number of Ph.D. level scientists moving into the field of
patent prosecution. Along with our experienced patent professionals, top caliber technical advisors
having varied academic and industry backgrounds complete our Life Sciences and Pharmaceuticals
Practice Group.
The Life Sciences and Pharmaceuticals Group's clients benefit from the Group's professionalism,
efficiency, and devotion to their clients' individual intellectual property needs. We provide
advice and counseling to medical and biotechnology companies including high-tech startups,
university laboratories, research institutions, and established biotechnology pioneers.
Our clients receive the personal attention that results in successful patent portfolios.
DCR's expertise extends into all areas of biotechnology including glycobiology, biochemistry,
immunology, microbiology, virology, genetics, developmental biology, cell biology, molecular biology,
pharmaceutical compositions, molecular diagnostics and techniques, and medical devices and equipment.
Additional highlights of DCR's Life Sciences and Pharmaceuticals Practice Group include:
- University of Oklahoma - Funding, organizing, and implementing the University of Oklahoma's Office of Technology Development. In support of OU's technology commercialization efforts, DCR has donated more than one million dollars in fees and services to OU's expanding technology transfer efforts.
- Cutting Edge Biotechnology - Securing intellectual property protection for the first process for producing individual endogenously loaded soluble HLA molecules and on the first recombinant methods for producing hyaluronic acid, chondroitin, and heparin. These patent portfolios have led to the creation of five biotechnology companies in several Oklahoma and Texas metroplexes.
- Electrophysiology - Securing broad platform intellectual property protection for preconditioning and treatment of an intrinsic cardiac nervous system utilizing an implantable electrical stimulus.
- Leveraging Patent Portfolios - Assisting in the acquisition and exploitation of patent portfolios of leading edge research in the areas of pharmaceuticals, drug formulation, medical technology, drug screening, inflammation inhibitors, regulation of skin pigmentation, testing for environmental pollution, novel treatments of septic shock, and water and food quality testing.
- Developing Portfolio Strategy - DCR's Life Sciences and Pharmaceutical Group believes that a pragmatic and strategic approach is necessary to ensure that every portfolio is strong on defense as well as on offense. Whether it is a core, a platform, a fence-picket or a poker-chip technology, DCR has the depth of experience and tools necessary to help our clients determine whether it is an asset or simply just an expense.
The multi-faceted proficiencies of the Life Sciences and Pharmaceuticals Practice Group
are a reflection of their extensive legal and scientific backgrounds including several
members holding Doctorate and other advanced degrees in Chemistry, Botany, Plant Physiology,
Population, Biochemistry and Molecular Biology. Members of the Life Sciences and Pharmaceuticals
Practice Group also serve as adjunct faculty members at several universities including
the University of Oklahoma Health Sciences Center and Oklahoma City University School of Law.
|
|
